X-376
Product Specifications
CAS Number
1365267-27-1
Target
C-Met/HGFR|||ALK
Related Pathways
Angiogenesis|||Tyrosine Kinase/Adaptors
Purity
0.9872
Bioactivity
X-376 (Ensartinib) is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity. Upon oral administration, X-396 binds to and inhibits ALK kinase, ALK fusion proteins, and ALK point mutation variants. Inhibition of ALK leads to the disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-expressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development.
Smiles
C[C@@H](Oc1cc(nnc1N)C(=O)Nc1ccc(cc1)C(=O)N1CCN(C)CC1)c1c(Cl)ccc(F)c1Cl
Molecular Formula
C25H25Cl2FN6O3
Molecular Weight
547.41
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15166754 1 Vial
Lentiviral mouse Tcl1b5 shRNA (UAS) - Lentiviral mouse Tcl1b5 shRNA (UAS, iRFP) (25)
Ask
View Details 
MBS7053980 Inquire
Recombinant Neisseria meningitidis serogroup A / serotype 4A ATP synthase subunit b (atpF), partial
Ask
View Details